PMGC (NASDAQ:ELAB – Get Free Report) released its earnings results on Friday. The company reported ($4.01) earnings per share for the quarter, FiscalAI reports. PMGC had a negative net margin of 522.92% and a negative return on equity of 118.83%. The company had revenue of $2.53 million during the quarter.
PMGC Stock Performance
Shares of NASDAQ ELAB traded down $0.01 during trading hours on Friday, reaching $1.58. The stock had a trading volume of 33,774 shares, compared to its average volume of 707,178. The business’s fifty day moving average is $3.26 and its two-hundred day moving average is $27.14. The company has a debt-to-equity ratio of 0.02, a current ratio of 1.36 and a quick ratio of 1.30. The company has a market cap of $1.28 million, a price-to-earnings ratio of -0.00 and a beta of -0.27. PMGC has a twelve month low of $1.41 and a twelve month high of $1,344.00.
Wall Street Analyst Weigh In
Separately, Weiss Ratings reissued a “sell (e+)” rating on shares of PMGC in a research report on Tuesday, September 22nd. One analyst has rated the stock with a Sell rating. Based on data from MarketBeat.com, the stock presently has an average rating of “Sell”.
Read Our Latest Report on ELAB
Institutional Investors Weigh In On PMGC
An institutional investor recently bought a new stake in PMGC stock. Citadel Advisors LLC acquired a new stake in PMGC Holdings Inc. (NASDAQ:ELAB – Free Report) in the second quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 20,702 shares of the company’s stock, valued at approximately $25,000. Citadel Advisors LLC owned approximately 2.56% of PMGC as of its most recent filing with the SEC. 22.22% of the stock is owned by institutional investors.
PMGC Company Profile
Elevai Labs, Inc., a skincare development company, designs, manufactures, and markets skincare products. Its products include Empower and Enfinity post-skincare procedure care serums for the face, neck, and upper chest regions. The company was formerly known as Reactive Medical Labs Inc. and changed its name to Elevai Labs, Inc. in December 2021. Elevai Labs, Inc. was incorporated in 2020 and is based in Newport Beach, California.
Read More
- Five stocks we like better than PMGC
- Intuitive Machines’ Business Is Taking Off—Will Its Stock Follow?
- The Next Big Thing May Not Be One Thing: Inside Lazard’s Megatrends ETF
- 3 Power and Grid Stocks That Could Keep Growing Even if AI Spending Slows
- Applied Materials Beats and Raises, But Investors Stay Unconvinced
Receive News & Ratings for PMGC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PMGC and related companies with MarketBeat.com's FREE daily email newsletter.
